Rouhandeh, Audrey A.
Honsberger, Christine
Shanok, Nathaniel A.
Lozott, Erin Brooker
Levy, Tess
Kolevzon, Alexander
Buxbaum, Joseph D.
Sotelo, Marlene
Foss-Feig, Jennifer
Siper, Paige M.
Funding for this research was provided by:
els for autism foundation
beatrice and samuel a. seaver foundation
Article History
Accepted: 22 April 2022
First Online: 26 May 2022
Declarations
:
: Dr. Kolevzon has received research support from AMO Pharma and has served as a consultant to Ovid, Alkermes, Ritrova, Acadia, and Jaguar Therapeutics.
: This study was approved by the Mount Sinai Program for the Protection of Human Subjects. All participants or their legal guardians provided informed consent prior to participation.
Free to read: This content has been made available to all.